ArticleMolecules (Basel, Switzerland)2022

Design of Novel Coumarin Derivatives as NUDT5 Antagonists That Act by Restricting ATP Synthesis in Breast Cancer Cells.

Vidya Niranjan et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.